Cargando…
Tumor-Specific Mitochondrial DNA Variants Are Rarely Detected in Cell-Free DNA()()
The use of blood-circulating cell-free DNA (cfDNA) as a “liquid biopsy” in oncology is being explored for its potential as a cancer biomarker. Mitochondria contain their own circular genomic entity (mitochondrial DNA, mtDNA), up to even thousands of copies per cell. The mutation rate of mtDNA is sev...
Autores principales: | Weerts, M.J.A., Timmermans, E.C., van de Stolpe, A., Vossen, R.H.A.M., Anvar, S.Y., Foekens, J.A., Sleijfer, S., Martens, J.W.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030393/ https://www.ncbi.nlm.nih.gov/pubmed/29842994 http://dx.doi.org/10.1016/j.neo.2018.05.003 |
Ejemplares similares
-
Sensitive detection of mitochondrial DNA variants for analysis of mitochondrial DNA-enriched extracts from frozen tumor tissue
por: Weerts, M. J. A., et al.
Publicado: (2018) -
Mitochondrial DNA content in breast cancer: Impact on in vitro and in vivo phenotype and patient prognosis
por: Weerts, Marjolein J.A., et al.
Publicado: (2016) -
Mitochondrial RNA Expression and Single Nucleotide Variants in Association with Clinical Parameters in Primary Breast Cancers
por: Weerts, Marjolein J. A., et al.
Publicado: (2018) -
Cell-free DNA mutations as biomarkers in breast cancer patients receiving tamoxifen
por: Jansen, Maurice P.H.M., et al.
Publicado: (2016) -
Somatic Tumor Mutations Detected by Targeted Next Generation Sequencing in Minute Amounts of Serum-Derived Cell-Free DNA
por: Weerts, Marjolein J. A., et al.
Publicado: (2017)